Professor Mandy MacLean has been awarded a Senior Research Fellowship by the Royal Society Leverhulme Trust – adding to her long list of honours.

The fellowship, one of seven that were awarded, will allow Prof MacLean to spend time focusing on her research while her teaching and administrative duties are taken over by a teaching replacement funded by the scheme.

Prof MacLean, who directs a research group studying the pharmacology of the pulmonary circulation will examine the roles of serotonin, gender and oestrogen in pulmonary arterial hypertension. This is a disease that causes right heart failure and for which there is no cure.

The fellowship is the latest in a series of prizes and awards this year for Prof MacLean who was awarded an MBE in 2010 for services to science – the same year she was given a Royal Society Wolfson Research Merit Award.

Only a couple of weeks ago Prof MacLean won the AstraZeneca Prize for Women in Pharmacology from the British Pharmacological Society for her outstanding research contribution to the field, and in June she was made a Fellow of the Royal Society of Edinburgh.

Prof MacLean said: “I am delighted to have been awarded this fellowship which will allow me to devote my time to this research that will help us to understand this very serious disease and why women get the disease more frequently than men.”

The Royal Society Leverhulme Trust Senior Research Fellowships cover all areas of the life and physical sciences, including engineering, but excluding clinical medicine.

The Leverhulme Trust was established in 1925 under the Will of the First Viscount Leverhulme with the instruction that its resources should be used to support “scholarships for the purposes of research and education.” More information is available from http://www.leverhulme.ac.uk/.

For more information contact Stuart Forsyth in the University of Glasgow Media Relations Office on 0141 330 4831 or email stuart.forsyth@glasgow.ac.uk

First published: 9 August 2013

<< August